| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |